STMN1 and metastatic malignant neoplasm: Thus, selectively preventing Stathmin 1 serine 16 phosphorylation may provide an alternative strategy for inhibiting growth factor-mediated metastatic cell growth in combination with current therapies used to eliminate metastatic cancer cells while preventing/inhibiting further metastasis.